Galapagos NV
GLPG
$28.63
Share price
-0.49%
Change (1 day)
-25.38%
Change (1 year)
Categories
Number of shares outstanding for Galapagos NV (GLPG)
Number of shares outstanding as of April 2024 : 66,305,714
According to Galapagos NV's latest financial reports and stock price the company's current number of shares outstanding is 66,305,714. At the end of 2023 the company had 66,305,714 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Galapagos NV from 2015 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 66.3 M | 0.71% |
| 2022 | 65.83 M | 0.47% |
| 2021 | 65.53 M | 0.01% |
| 2020 | 65.52 M | 13.55% |
| 2019 | 57.7 M | 12.76% |
| 2018 | 51.17 M | 2.05% |
| 2017 | 50.14 M | 12.88% |
| 2016 | 44.42 M | 46.47% |
| 2015 | 30.33 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 3,530.46% | 🇺🇸 USA |
 Abbott Laboratories ABT | 1,734,076,358 | 2,515.27% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 2,563.33% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | 3,681.27% | 🇫🇷 France |
 Merck MRK | 2,554,166,667 | 3,752.11% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 4,572.30% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 2,958.56% | 🇬🇧 UK |
 Fortress Biotech
FBIO | 7,494,905 | -88.70% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 1,590.65% | 🇮🇱 Israel |